Targeted Biologic Therapy for Systemic Lupus Erythematosus: Emerging Pathways and Drug Pipeline
Kalliopi Klavdianou, Argyro Lazarini, Antonis Fanouriakis
Topics & Concepts
MedicineBelimumabClinical trialDrugDrug developmentDiseaseDrug repositioningSystemic lupus erythematosusIntensive care medicineImmunologyBioinformaticsPharmacologyInternal medicineAntibodyB-cell activating factorB cellBiologySystemic Lupus Erythematosus ResearchMonoclonal and Polyclonal Antibodies ResearchChronic Lymphocytic Leukemia Research